Pharmacoscintigraphic Investigation NN9924 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 15 Sep 2017 Results of this and other study assessing absorption of semaglutide, presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 13 Jun 2017 Results (n=26) presented at the 77th Annual Scientific Sessions of the American Diabetes Association.